Gastro-resistant tablet 20 mg: Pantoprazole is indicated for use in adults and adolescents 12 years of age and above for: Symptomatic gastro-oesophageal reflux disease; Long-term management and prevention of relapse in reflux oesophagitis.
Pantoprazole is indicated for use in adults for: Prevention of gastroduodenal ulcers induced by non-selective non-steroidal anti-inflammatory drugs (NSAIDs) in patients at risk with a need for continuous NSAID treatment (see Precautions).
Gastro-resistant tablet 40 mg: Pantoprazole is indicated for use in adults and adolescents 12 years of age and above for: Reflux oesophagitis.
Pantoprazole is indicated in adults for: Eradication of Helicobacter pylori (H. pylori) in combination with appropriate antibiotic therapy in patients with H. pylori associated ulcers; Gastric and duodenal ulcer; Zollinger-Ellison-Syndrome and other pathological hypersecretory conditions.
Powder for solution for injection: Pantoloc i.v. is indicated for use in adults for: Reflux oesophagitis; Gastric and duodenal ulcer; Zollinger-Ellison-Syndrome and other pathological hypersecretory conditions.